These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19861688)

  • 1. P-REX2a driving tumorigenesis by PTEN inhibition.
    Leslie NR
    Sci Signal; 2009 Oct; 2(94):pe68. PubMed ID: 19861688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a.
    Fine B; Hodakoski C; Koujak S; Su T; Saal LH; Maurer M; Hopkins B; Keniry M; Sulis ML; Mense S; Hibshoosh H; Parsons R
    Science; 2009 Sep; 325(5945):1261-5. PubMed ID: 19729658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis.
    Hodakoski C; Hopkins BD; Barrows D; Mense SM; Keniry M; Anderson KE; Kern PA; Hawkins PT; Stephens LR; Parsons R
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):155-60. PubMed ID: 24367090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
    Cully M; You H; Levine AJ; Mak TW
    Nat Rev Cancer; 2006 Mar; 6(3):184-92. PubMed ID: 16453012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of P-REX2a may inhibit proliferation and reverse the resistance of SGC7901 cells to doxorubicin.
    Ai Y; Zhou Q; Li L; Pan Z; Guo M; Han J
    Oncol Lett; 2018 Mar; 15(3):3185-3191. PubMed ID: 29435055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.
    Ciuffreda L; Falcone I; Incani UC; Del Curatolo A; Conciatori F; Matteoni S; Vari S; Vaccaro V; Cognetti F; Milella M
    Adv Biol Regul; 2014 Sep; 56():66-80. PubMed ID: 25088603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
    Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
    Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN mutation: many birds with one stone in tumorigenesis.
    Liu W; Zhou Y; Reske SN; Shen C
    Anticancer Res; 2008; 28(6A):3613-9. PubMed ID: 19189642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
    Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
    Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles.
    Stiles BL
    Int J Biochem Cell Biol; 2009 Apr; 41(4):757-61. PubMed ID: 18950730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN and the PI3-kinase pathway in cancer.
    Chalhoub N; Baker SJ
    Annu Rev Pathol; 2009; 4():127-50. PubMed ID: 18767981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
    Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
    Steelman LS; Abrams SL; Whelan J; Bertrand FE; Ludwig DE; Bäsecke J; Libra M; Stivala F; Milella M; Tafuri A; Lunghi P; Bonati A; Martelli AM; McCubrey JA
    Leukemia; 2008 Apr; 22(4):686-707. PubMed ID: 18337767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic switching of PI3K-dependent lipid signals.
    Downes CP; Leslie NR; Batty IH; van der Kaay J
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):188-92. PubMed ID: 17371235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.